NO883495D0 - Mot neutrofili spesifikt monoklonalt antistoff. - Google Patents

Mot neutrofili spesifikt monoklonalt antistoff.

Info

Publication number
NO883495D0
NO883495D0 NO883495A NO883495A NO883495D0 NO 883495 D0 NO883495 D0 NO 883495D0 NO 883495 A NO883495 A NO 883495A NO 883495 A NO883495 A NO 883495A NO 883495 D0 NO883495 D0 NO 883495D0
Authority
NO
Norway
Prior art keywords
monoclonal antibody
human
reactivity
cells
neutrophily
Prior art date
Application number
NO883495A
Other languages
English (en)
Other versions
NO174855B (no
NO883495L (no
NO174855C (no
Inventor
James D Griffin
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of NO883495D0 publication Critical patent/NO883495D0/no
Publication of NO883495L publication Critical patent/NO883495L/no
Publication of NO174855B publication Critical patent/NO174855B/no
Publication of NO174855C publication Critical patent/NO174855C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO883495A 1986-12-08 1988-08-05 Monoklonalt antistoff og cellelinje som produserer dette NO174855C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93886486A 1986-12-08 1986-12-08
US07/070,202 US4931395A (en) 1986-12-08 1987-07-06 Monoclonal antibody specific to neutrophils
PCT/US1987/003035 WO1988004320A1 (en) 1986-12-08 1987-11-17 Monoclonal antibody specific to neutrophils

Publications (4)

Publication Number Publication Date
NO883495D0 true NO883495D0 (no) 1988-08-05
NO883495L NO883495L (no) 1988-08-05
NO174855B NO174855B (no) 1994-04-11
NO174855C NO174855C (no) 1994-07-20

Family

ID=26750894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883495A NO174855C (no) 1986-12-08 1988-08-05 Monoklonalt antistoff og cellelinje som produserer dette

Country Status (14)

Country Link
US (1) US4931395A (no)
EP (1) EP0338003B1 (no)
JP (2) JP2554153B2 (no)
KR (1) KR960013131B1 (no)
CN (1) CN1024285C (no)
AT (1) ATE88751T1 (no)
AU (1) AU611407B2 (no)
CA (1) CA1283066C (no)
DE (1) DE3785673T2 (no)
DK (1) DK440988A (no)
IL (1) IL84595A0 (no)
MX (1) MX9203237A (no)
NO (1) NO174855C (no)
WO (1) WO1988004320A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils
IE67038B1 (en) * 1988-12-22 1996-02-21 Patrick Joseph Joyce Immunodiagnostic assays for use in the detection and determination of mastitis
US5348859A (en) * 1990-11-23 1994-09-20 Coulter Corporation Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
US5814468A (en) * 1996-03-27 1998-09-29 Coulter International Corp. Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution
US6696243B2 (en) 2001-01-23 2004-02-24 Coulter International Corp. Method for the analysis of soluble analytes
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US20070110737A1 (en) * 2003-12-29 2007-05-17 Allan Mishra Compositions and method for decreasing the appearance of skin wrinkles
WO2005065242A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Method of treating cancer using platelet releasate
WO2005065419A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Method of culturing cells
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils

Also Published As

Publication number Publication date
MX9203237A (es) 1992-07-01
JP2667140B2 (ja) 1997-10-27
DE3785673T2 (de) 1993-08-19
AU611407B2 (en) 1991-06-13
WO1988004320A1 (en) 1988-06-16
DK440988D0 (da) 1988-08-05
IL84595A0 (en) 1988-04-29
EP0338003B1 (en) 1993-04-28
JPH02501029A (ja) 1990-04-12
ATE88751T1 (de) 1993-05-15
DE3785673D1 (de) 1993-06-03
AU1046088A (en) 1988-06-30
EP0338003A1 (en) 1989-10-25
NO174855B (no) 1994-04-11
KR960013131B1 (ko) 1996-09-30
KR890700161A (ko) 1989-03-10
NO883495L (no) 1988-08-05
CN87107275A (zh) 1988-08-17
DK440988A (da) 1988-08-05
US4931395A (en) 1990-06-05
CN1024285C (zh) 1994-04-20
JP2554153B2 (ja) 1996-11-13
CA1283066C (en) 1991-04-16
JPH08275775A (ja) 1996-10-22
NO174855C (no) 1994-07-20
EP0338003A4 (en) 1990-01-26

Similar Documents

Publication Publication Date Title
NO883495D0 (no) Mot neutrofili spesifikt monoklonalt antistoff.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
KR880006357A (ko) 인터류킨-i에 대한 항체
IL86676A0 (en) Cell line and monoclonal antibodies
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DE69020007D1 (de) Vernetzte Antikörper und Verfahren zu ihrer Herstellung.
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
EP0232871A3 (en) Human monoclonal antibody, hybridoma producing the same and its use
ES547051A0 (es) Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
EP0204522A3 (en) Monoclonal antibody panel for histocompatibility typing
ZA904229B (en) Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
ES2010761A6 (es) Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
ES2008956A6 (es) Un procedimiebto para obtener una linea de celulas hibridas capaces deproducir anticuerpos monoclonales singularmente especificos de los neutrofilos humanos.
DE59207362D1 (de) Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
JPS6490198A (en) Monoclonal antibody, its production and reagent consisting thereof for detecting virus
DE3852601D1 (de) An Krebszellen bindendes Antigen.
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.